Global Retirement Partners’s Vivos Therapeutics VVOS Stock Holding History

Global Retirement Partners’s Portfolio VVOS Stock Details VVOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10	Buy	+23	New	+$18	﹤0.01%	4498
2025 Q4	–	Sell	-23	Closed	-$71	–	4430
2025 Q3	$71	Hold	23	–	–	﹤0.01%	3808
2025 Q2	$73	Buy	+23	New	+$58	﹤0.01%	3734
2024 Q4	$99	Hold	23	–	–	﹤0.01%	3550
2024 Q3	$60	Hold	23	–	–	﹤0.01%	3434
2024 Q2	$51	Hold	23	–	–	﹤0.01%	3487
2024 Q1	$111	Hold	23	–	–	﹤0.01%	3293
2023 Q4	$165	Hold	23	–	–	﹤0.01%	3244
2023 Q3	$174	Hold	23	–	–	﹤0.01%	3129
2023 Q2	$291	Hold	23	–	–	﹤0.01%	3055
2023 Q1	$182	Hold	23	–	–	﹤0.01%	3094
2022 Q4	$229	Hold	23	–	–	﹤0.01%	2929
2022 Q3	$0	Hold	23	–	–	﹤0.01%	3010
2022 Q2	$1K	Hold	23	–	–	﹤0.01%	2597
2022 Q1	$1K	Buy	+23	New	+$1.5K	﹤0.01%	2550
2021 Q4	–	Sell	-23	Closed	-$2K	–	1787
2021 Q3	$2K	Hold	23	–	–	﹤0.01%	1857
2021 Q2	$3K	Buy	+23	New	+$3.75K	﹤0.01%	1697

Other funds holding VVOS

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CWM

Centurion Wealth Management Mclean, Virginia $418M AUM 23.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Global Retirement Partners's VVOS Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Vivos Therapeutics (VVOS) in Q2 2026: 23 shares worth $10. The stake represents ﹤0.01% of the portfolio and ranks #4498 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in VVOS as recently as Q3 2025.

Global Retirement Partners first reported a position in VVOS in Q2 2021 and has held it in 17 quarters since. The position peaked at $3K in Q2 2021. 23 funds tracked by Wall St. Rank hold VVOS as of Q2 2026.

Global Retirement Partners held 23 shares of Vivos Therapeutics worth $10 as of Q2 2026.
Vivos Therapeutics was a new Global Retirement Partners position in Q2 2026.
Vivos Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #4498 holding.
Global Retirement Partners first reported a position in Vivos Therapeutics in Q2 2021 and has held it in 17 quarters since.
Global Retirement Partners's Vivos Therapeutics position peaked at $3K in Q2 2021.
23 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.